This October 2022, in honour of Liver Cancer Awareness Month, EASL participated in organising two important advocacy events aimed at identifying and implementing strategies to enhance awareness of liver cancer and engage key policymakers at the EU level. [vc_custom_heading text=”The Final Push t…
Amsterdam, October 6, 2022 – A new analysis reveals that primary liver cancer was among the top three causes of…
On 12-14 September 2022, representatives from civil society, partnering organizations, and the 53 Member States of the WHO European Region met in Tel Aviv, Israel for the 72nd governance session. The session was designed to assess progress and establish next steps for implementing the European Pr…
Amsterdam, September 26, 2022 – Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for…
From the very beginning, EASL’s mission has been to be the “Home of Hepatology”. Providing education to everyone interested in hepatology and engaging with all stakeholders in the liver field wherever they are based. Through its 66 years of existence, EASL has become a leading association in hepa…
Although DAA medications have demonstrated excellent safety and efficacy in non-pregnant individuals, they are not currently approved for HCV treatment in pregnant women due to a lack of safety data. Clinical trials assessing the safety of DAAs in pregnancy and real-world studies regarding the ou…
The 2-day meeting in Chicago on 8-9 July 2022 convened 129 consensus survey participants in person or online. The participants originated from 32 countries, representing multiple societies including AASLD, EASL, APASL, ALEH, AGA and UEG, patients and patient advocacy organizations, regulators and…
28 July 2022 Channel 4 News from London: Liver disease deaths in the UK have soared by 400% since 1970 with an average of 40 deaths per day. We know that liver transplantation remains a radical, expensive and risky option, while 90% of liver disease is in fact preventable. EASL’s Prof. Emmanuel …
28 July 2022 This World Hepatitis Day, EASL revoices commitment to working towards the elimination of viral hepatitis and striving towards the World Health Organization’s goal of a hepatitis-free world by 2030. To mark this important day, we are launching the EASL Policy Dialogues video series, p…
Prof. Vinay Sundaram, Associate Professor of Medicine and Director of Hepatology Outcomes Research at Cedars-Sinai Medical Center, passed away on July 14, 2022. Prof. Sundaram was one of the leading researchers in the field of acute-on-chronic liver failure and was actively involved in studies ai…
